SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-23-000048
Filing Date
2023-11-07
Accepted
2023-11-07 17:14:52
Documents
96
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tvtx-20230930.htm   iXBRL 10-Q 1693105
2 EX-31.1 tvtx-09302023x10qxex311.htm EX-31.1 12717
3 EX-31.2 tvtx-09302023x10qxex312.htm EX-31.2 12412
4 EX-32.1 tvtx-09302023x10qxex321.htm EX-32.1 8776
5 EX-32.2 tvtx-09302023x10qxex322.htm EX-32.2 8856
11 GRAPHIC tvtx-20230930_g1.jpg GRAPHIC 104754
  Complete submission text file 0001438533-23-000048.txt   9277552

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvtx-20230930.xsd EX-101.SCH 58427
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tvtx-20230930_cal.xml EX-101.CAL 112221
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tvtx-20230930_def.xml EX-101.DEF 386006
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvtx-20230930_lab.xml EX-101.LAB 822538
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvtx-20230930_pre.xml EX-101.PRE 575677
90 EXTRACTED XBRL INSTANCE DOCUMENT tvtx-20230930_htm.xml XML 1178719
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 231385081
SIC: 2834 Pharmaceutical Preparations